To Study GSP 301 in Patients With Seasonal Allergic Rhinitis

Completed · Phase 2 · Has a placebo group

Conditions studied: Seasonal Allergic Rhinitis

In brief

Study to evaluate the two different strengths and dose regimen of GSP 301 to be effective in treatment of seasonal allergic rhinitis.

Key facts

Study ID

NCT02318303

Run by

Glenmark Pharmaceuticals Ltd. India

People needed

1111

Starts

2014-12-01

Expected to finish

2015-02-01

Last updated by the study team

2020-10-20

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Glenmark Investigational Site 10 — Austin, Texas, United States
• Glenmark Investigational Site 5 — Austin, Texas, United States
• Glenmark Investigational Site 6 — Austin, Texas, United States
• Glenmark Investigational Site 2 — Kerrville, Texas, United States
• Glenmark Investigational Site 7 — New Braunfels, Texas, United States
• Glenmark Investigational Site 3 — San Antonio, Texas, United States
• Glenmark Investigational Site 4 — San Antonio, Texas, United States
• Glenmark Investigational Site 8 — San Antonio, Texas, United States
• Glenmark Investigational Site 9 — San Antonio, Texas, United States
• Glenmark Investigational Site 1 — Waco, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.